0001826457-20-000001.txt : 20200929 0001826457-20-000001.hdr.sgml : 20200929 20200929151454 ACCESSION NUMBER: 0001826457-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200929 DATE AS OF CHANGE: 20200929 EFFECTIVENESS DATE: 20200929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc. CENTRAL INDEX KEY: 0001826457 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-376612 FILM NUMBER: 201208619 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02458 BUSINESS PHONE: 917-363-0113 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02458 D 1 primary_doc.xml X0708 D LIVE 0001826457 Monte Rosa Therapeutics, Inc. 40 GUEST STREET BOSTON MA MASSACHUSETTS 02458 917-363-0113 DELAWARE None None Corporation true 2019 Markus Warmuth 40 Guest Street Boston MA MASSACHUSETTS 02458 Executive Officer Director Alexander Mayweg 40 Guest Street Boston MA MASSACHUSETTS 02458 Director Bradley Bolzon 40 Guest Street Boston MA MASSACHUSETTS 02458 Director Ali Behbahani 40 Guest Street Boston MA MASSACHUSETTS 02458 Director Kim Blackwell 40 Guest Street Boston MA MASSACHUSETTS 02458 Director Biotechnology Decline to Disclose 06b false 2020-09-14 false true false 0 96000000 48000000 48000000 false 17 0 0 0 false Monte Rosa Therapeutics, Inc. /s/Markus Warmuth, M.D. Markus Warmuth, M.D. Chief Executive Officer and President 2020-09-29